Answers are grounded in this paper and cite their sources.
Joint diseases and injuries substantially impair daily activities. Continuous monitoring of joint function offers a powerful approach to assessing joint health and guiding therapeutic interventions. This Review begins with the pathophysiology of joint diseases and critically examines flexible bioelectronic sensors designed to monitor distinct physiological features associated with osteoarthritis, rheumatoid arthritis, gouty arthritis, and ligament injuries. We discuss the sensing mechanisms, developmental stages, and challenges in clinical translation of these devices. Currently, inertial sensing is the only technology that has entered clinical evaluation; most other sensors remain at an early developmental stage, with a considerable gap yet to be bridged before clinical application. Advances in flexible electronics, self‑powered operation and wireless transmission are steering these sensors toward personalized home‑based healthcare monitoring. However, the lack of standardized data protocols, low system integration, unverified long‑term reliability, and insufficient clinical sample sizes constitute major barriers to translation. Finally, we outline the functional requirements for next‑generation sensors designed for continuous, long‑term monitoring of joint diseases: future systems should prioritize high precision with unified data standards, high integration with robust fatigue resistance, and multimodality with proven biosafety.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: